StonvexLoading…
StonvexStonvexStonvexCore line items from EBC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $134.09M | $112.62M | $76.87M | $77.30M |
Operating Income | $99.51M | $155.77M | $-126.00M | $238.23M |
Net Income | $88.22M | $119.56M | $232.18M | $199.76M |
EPS (Diluted) | $0.43 | $0.66 | $1.43 | $1.21 |
Total Assets | $30.59B | $25.56B | $21.13B | $22.65B |
Total Liabilities | $26.25B | $21.95B | $18.16B | $20.18B |
Cash & Equivalents | $316.87M | $1.01B | $693.08M | $169.50M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 235.65M | 213.91M | 176.43M | 176.17M |